Literature DB >> 3384911

Influence of strain characteristics and immunity on the epidemiology of Campylobacter infections in Thailand.

D N Taylor1, P Echeverria, C Pitarangsi, J Seriwatana, L Bodhidatta, M J Blaser.   

Abstract

To determine how strain differences and immunity affect the clinical expression of Campylobacter infections, we conducted a study of acute diarrheal disease in Thailand in which specimens from children with Campylobacter infections were cultured weekly for up to 12 weeks to determine the serotype-specific length of time of convalescent-phase excretion and rate of reinfection. Levels of immunoglobulin G to cell-surface antigens of C. jejuni were determined in another population of healthy children who were closely related by age and location to the children in the diarrheal disease study. Campylobacter species were initially isolated from 18% of 586 children under 5 years old with diarrhea; most isolates in Thailand belonged to serotypes commonly found in developed countries. C. coli was significantly less often associated with symptomatic infections and with bloody diarrhea than C. jejuni (P less than 0.001 and P = 0.045, respectively). The peak age of isolation and the peak level of immunoglobulin G to Campylobacter species occurred before 2 years of age. The mean duration of convalescent-phase excretion was 14 +/- 2 (standard error of the mean) days for children less than 1 year old and 8 +/- 2 days for children 1 to 5 years old (P = 0.02, t test). Infection with another Campylobacter serotype was found in 34% of 105 children during the 12-week follow-up period. The rate of reinfection in these children was 15% (range, 8 to 22%) each week. Hyperendemic exposure to Campylobacter species in Thailand confers immunity to infection that is associated with an early peak in specific serum antibodies and an age-related decrease in the case-to-infection ratio and duration of convalescent-phase excretion but does not prevent asymptomatic infections.

Entities:  

Mesh:

Year:  1988        PMID: 3384911      PMCID: PMC266475          DOI: 10.1128/jcm.26.5.863-868.1988

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  36 in total

1.  Phagocytosis of Campylobacter jejuni and C. coli by peritoneal macrophages.

Authors:  E Banfi; M Cinco; G Zabucchi
Journal:  J Gen Microbiol       Date:  1986-08

Review 2.  Campylobacter enteritis.

Authors:  M J Blaser; L B Reller
Journal:  N Engl J Med       Date:  1981-12-10       Impact factor: 91.245

3.  Test for enterotoxigenic Escherichia coli using Y-1 adrenal cells in miniculture.

Authors:  D A Sack; R B Sack
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

4.  Cytotoxic and cytotonic factors produced by Campylobacter jejuni, Campylobacter coli, and Campylobacter laridis.

Authors:  W M Johnson; H Lior
Journal:  J Clin Microbiol       Date:  1986-08       Impact factor: 5.948

5.  Long-term infections with Campylobacter fetus subsp. jejuni.

Authors:  N J Richardson; H J Koornhof; V D Bokkenheuser
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

6.  Campylobacter fetus subspecies jejuni: a common cause of diarrhea in Sweden.

Authors:  A Svedhem; B Kaijser
Journal:  J Infect Dis       Date:  1980-09       Impact factor: 5.226

7.  Test for Escherichia coli enterotoxin using infant mice: application in a study of diarrhea in children in Honolulu.

Authors:  A G Dean; Y C Ching; R G Williams; L B Harden
Journal:  J Infect Dis       Date:  1972-04       Impact factor: 5.226

8.  Detection of enteric campylobacteriosis in children.

Authors:  V D Bokkenheuser; N J Richardson; J H Bryner; D J Roux; A B Schutte; H J Koornhof; I Freiman; E Hartman
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

9.  Campylobacter enteritis: clinical and epidemiologic features.

Authors:  M J Blaser; I D Berkowitz; F M LaForce; J Cravens; L B Reller; W L Wang
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

10.  Campylobacter enteritis in children.

Authors:  M A Karmali; P C Fleming
Journal:  J Pediatr       Date:  1979-04       Impact factor: 4.406

View more
  25 in total

1.  Novel insight in the association between salmonellosis or campylobacteriosis and chronic illness, and the role of host genetics in susceptibility to these diseases.

Authors:  Y Doorduyn; W Van Pelt; C L E Siezen; F Van Der Horst; Y T H P Van Duynhoven; B Hoebee; R Janssen
Journal:  Epidemiol Infect       Date:  2007-12-07       Impact factor: 2.451

2.  New World monkey Aotus nancymae as a model for Campylobacter jejuni infection and immunity.

Authors:  Franca R Jones; Shahida Baqar; Alfonso Gozalo; Gladys Nunez; Nereyda Espinoza; Sharina M Reyes; Milagros Salazar; Rina Meza; Chad K Porter; Stephen E Walz
Journal:  Infect Immun       Date:  2006-01       Impact factor: 3.441

Review 3.  A capsule conjugate vaccine approach to prevent diarrheal disease caused by Campylobacter jejuni.

Authors:  Alexander C Maue; Frédéric Poly; Patricia Guerry
Journal:  Hum Vaccin Immunother       Date:  2014-03-14       Impact factor: 3.452

4.  Campylobacter jejuni isolations from Mexican and Swedish patients, with repeated symptomatic and/or asymptomatic diarrhoea episodes.

Authors:  E Sjögren; G Ruiz-Palacios; B Kaijser
Journal:  Epidemiol Infect       Date:  1989-02       Impact factor: 2.451

5.  Experimental Campylobacter jejuni infection in Macaca nemestrina.

Authors:  R G Russell; M J Blaser; J I Sarmiento; J Fox
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

6.  Assessment of the duration of protection in Campylobacter jejuni experimental infection in humans.

Authors:  David R Tribble; Shahida Baqar; Daniel A Scott; Michael L Oplinger; Fernando Trespalacios; David Rollins; Richard I Walker; John D Clements; Steven Walz; Paul Gibbs; Edward F Burg; Anthony P Moran; Lisa Applebee; A Louis Bourgeois
Journal:  Infect Immun       Date:  2010-01-19       Impact factor: 3.441

Review 7.  Human campylobacteriosis in developing countries.

Authors:  Akitoye O Coker; Raphael D Isokpehi; Bolaji N Thomas; Kehinde O Amisu; C Larry Obi
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

8.  PFGE, Lior serotype, and antimicrobial resistance patterns among Campylobacter jejuni isolated from travelers and US military personnel with acute diarrhea in Thailand, 1998-2003.

Authors:  Oralak Serichantalergs; Piyarat Pootong; Anders Dalsgaard; Ladaporn Bodhidatta; Patricia Guerry; David R Tribble; Sinn Anuras; Carl J Mason
Journal:  Gut Pathog       Date:  2010-11-10       Impact factor: 4.181

9.  Evidence of reinfection with multiple strains of Campylobacter jejuni and Campylobacter coli in Macaca nemestrina housed under hyperendemic conditions.

Authors:  R G Russell; J I Sarmiento; J Fox; P Panigrahi
Journal:  Infect Immun       Date:  1990-07       Impact factor: 3.441

Review 10.  Host-pathogen interactions in Campylobacter infections: the host perspective.

Authors:  Riny Janssen; Karen A Krogfelt; Shaun A Cawthraw; Wilfrid van Pelt; Jaap A Wagenaar; Robert J Owen
Journal:  Clin Microbiol Rev       Date:  2008-07       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.